Addus HomeCare Corporation
NASDAQ:ADUSMedical - Care Facilities
+$0.29 today
- Market cap
- $2.25B
- Beta
- 0.90
- P/E (TTM)
- 17.4
- EPS (TTM)
- $5.40
Volume 0.23M
Average 0.25M
ADUS Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Addus HomeCare CorporationNASDAQ: ADUS
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q2 FY2026 depreciation & amortization of $4.13M rose 5.4% year over year, behind the +15.1% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 2.4% from the prior quarter. Over 3 fiscal years it compounded at +5.3% a year.
Context
- Depreciation & amortization amounted to 1.2% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +5.4% toward the trailing-twelve-month pace of +15.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 16.41M USD
- Year-over-year change
- +21.3%
- 4-year CAGR
- +3.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 16.41M | +21.3% |
| FY2024 | 2024-12-31 | 13.53M | -4.2% |
| FY2023 | 2023-12-31 | 14.13M | +0.5% |
| FY2022 | 2022-12-31 | 14.06M | -3.0% |
| FY2021 | 2021-12-31 | 14.49M | — |
Depreciation & Amortization vs competitors
How ADUS compares with its peers on the latest reported figures
- ADUS's LTM Jun 2026 depreciation & amortization of $16.71M is the 6th highest of the 7 companies compared; the peer median is $57.78M.
- Its year-over-year change of +15.1% is the 3rd highest of 7, against a peer median of +10.0%.
- Depreciation & amortization amounts to 1.1% of revenue for ADUS, versus a peer median of 2.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $346.5M | +9.8% | +10.4% | 5.6% | |
| LTM Jun 2026 | $114.56M | +21.9% | +18.7% | 2.1% | |
| LTM Jun 2026 | $66.42M | +4.1% | +3.1% | 2.6% | |
| LTM Sep 2026 | $49.13M | +10.2% | +3.5% | 3.1% | |
| LTM Oct 2026 | $25.54M | -9.6% | -10.1% | 1.0% | |
| LTM Jun 2026 | $16.71M | +15.1% | +5.3% | 1.1% | |
| LTM Mar 2026 | $9.26M | +38.7% | +20.3% | 0.9% | |
| Peer median (excluding ADUS) | $57.78M | +10.0% | +7.0% | 2.3% | |
Competitors are the stored peer set for ADUS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 864.5M | 951.12M | 1.06B | 1.15B | 1.42B |
| Cost of Revenue | 595.24M | 651.38M | 718.78M | 779.58M | 960.66M |
| Gross Profit | 269.85M | 299.74M | 339.88M | 375.02M | 461.87M |
| Gross Margin | 31.2% | 31.5% | 32.1% | 32.5% | 32.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 189.42M | 216.94M | 231.68M | 258.8M | 306.85M |
| Operating Expenses | 203.32M | 231M | 248.92M | 272.33M | 323.26M |
| Depreciation & Amortization | 14.49M | 14.06M | 14.13M | 13.53M | 16.41M |
| EBITDA | 80.7M | 83.14M | 106.56M | 120.62M | 153.44M |
| EBITDA Margin | 9.3% | 8.7% | 10.1% | 10.4% | 10.8% |
| Operating Income | 65.94M | 68.74M | 90.96M | 102.69M | 138.62M |
| Operating Margin | 7.6% | 7.2% | 8.6% | 8.9% | 9.7% |
| Interest Income | 268K | 341K | 1.48M | 4.39M | 1.59M |
| Interest Expense | 5.81M | 8.91M | 11.11M | 7.73M | 9.58M |
| Other Income / Expenses | (5.54M) | (8.57M) | (9.63M) | (3.34M) | (11.17M) |
| Income Before Tax | 60.4M | 60.17M | 81.33M | 99.35M | 127.45M |
| Pre-Tax Margin | 7.0% | 6.3% | 7.7% | 8.6% | 9.0% |
| Income Tax Expense | 15.27M | 14.15M | 18.81M | 25.76M | 31.54M |
| Net Income | 45.13M | 46.03M | 62.52M | 73.6M | 95.91M |
| Net Margin | 5.2% | 4.8% | 5.9% | 6.4% | 6.7% |
| EPS (Basic) | 2.87 | 2.90 | 3.91 | 4.33 | 5.19 |
| EPS (Diluted) | 2.81 | 2.84 | 3.83 | 4.23 | 5.21 |
| Weighted Avg Shares | 15.74M | 16.13M | 16.23M | 17.01M | 18.45M |
| Weighted Avg Shares (Diluted) | 16.06M | 16.18M | 16.31M | 17.38M | 18.45M |
Addus HomeCare Corporation
NASDAQ:ADUS
Intrinsic Alpha fair value
Locked
Current Price
$120.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.